Christopher H. Hawkes
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Lessons in neuroimmunology from the retracted avacopan trial paper.
Journal: Multiple sclerosis and related disorders
Published: August 08, 2026
A new HANDling of progressive MS and progressive MS trials.
Journal: Multiple sclerosis and related disorders
Published: June 09, 2026
The case for seronegative MOG antibody syndrome (SMOGAS).
Journal: Multiple sclerosis and related disorders
Published: March 13, 2026
Tolebrutinib and the FDA.
Journal: Multiple sclerosis and related disorders
Published: February 13, 2026
Validity of model for predicting risk of relapse in MOGAD.
Journal: Multiple sclerosis and related disorders
Published: November 14, 2025
When does multiple sclerosis start?
Journal: Multiple sclerosis and related disorders
Published: September 14, 2025
Mental health as an unmet medical need in NMOSD: how can we do better?
Journal: Multiple sclerosis and related disorders
Published: June 06, 2025
Vitamin D- should we all take it?
Journal: Multiple sclerosis and related disorders
Published: May 08, 2025
Infectious mononucleosis is a more realistic target for preventing multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: February 22, 2025
Potential mechanisms of how B-cell depletion works in MOGAD.
Journal: Multiple sclerosis and related disorders
Published: January 19, 2025
Smouldering-associated worsening or SAW: the next therapeutic challenge in managing multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: December 03, 2024
Can placebo-controlled phase 2 disease-modifying therapy trials in MS still be justified?
Journal: Multiple sclerosis and related disorders
Published: June 08, 2024
Last Updated: 09/26/2026